Nicole M Nazario-Maldonado

Ms. Nicole M Nazario-Maldonado

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2021 in Viruses
Verified
Journal Article
Open access
PDF file
CSCaroline J. Stephenson
Caroline J. Stephenson
HCHeather Coatsworth
Heather Coatsworth
CWChristy M. Waits
Christy M. Waits
NNNicole M Nazario-Maldonado
Nicole M Nazario-Maldonado
DMDerrick Mathias
Derrick Mathias
JLJohn A. Lednicky
John A. Lednicky
Dengue viruses (DENVs) cause the greatest public health burden globally among the arthropod-borne viruses. DENV transmission risk has also expanded from tropical to subtropical regions due to the increasing range of its principal mosquito vector, Aedes aegypti. Focal outbreaks of dengue fever (dengue) in the state of Florida (FL) in the USA have increased since 2009. However, little is known about the competence of Ae. aegypti populations across different regions of FL to transmit DENVs. To understand the effects of DENV genotype and serotype variations on vector susceptibility and transmission potential in FL, we orally infected a colony of Ae. aegypti (Orlando/ORL) with low passage or laboratory DENV-1 through -4. Low passage DENVs were more infectious to and had higher transmission potential by ORL mosquitoes. We used these same DENVs to examine natural Ae. aegypti populations to determine whether spatial distributions correlated with differential vector competence. Vector competence across all DENV serotypes was greater for mosquitoes from areas with the highest dengue incidence in south FL compared to north FL. Vector competence for low passage DENVs was significantly higher, revealing that transmission risk is influenced by virus/vector combinations. These data support a targeted mosquito-plus-pathogen screening approach to more accurately estimate DENV transmission risk.

3 July 2025
Verified
Book Chapter
Open access
PDF file
MMManuel Alejandro Mosso-Pani
Manuel Alejandro Mosso-Pani
Henry Puerta-GuardoHenry Puerta-Guardo
Henry Puerta-Guardo
DNDaniel Nunez-Avellaneda
Daniel Nunez-Avellaneda
NNNicole M Nazario-Maldonado
Nicole M Nazario-Maldonado
LPLuis Antonio Alonso Palomares
Luis Antonio Alonso Palomares
Arboviruses (arthropod-borne viruses) are etiological viral agents mainly transmitted by arthropod vectors that pose a significant burden on the human public health systems worldwide, causing millions of infections every year; these viruses need to replicate in hematophagous arthropods, including numerous species of mosquitoes, ticks, and midges, among others. Important arboviruses for human and animal health include the dengue virus (DENV), Mayaro virus (MAYV), Rift Valley fever virus (RVFV), Zika virus (ZIKV), Yellow fever virus (YFV), chikungunya (CHIKV), and African swine fever virus (ASF), among other closely related viruses. These infectious agents can infect different hosts (invertebrate vectors and mammalian hosts), which requires avoiding two types of immune responses to continue and remain in nature. Arboviruses have sylvatic (vector to wild animals) and urban (vector to humans) transmission cycles and have developed mechanisms to overcome ecological and biological challenges, allowing them to take over the cellular machinery and successfully complete their replication cycle among hosts. Despite numerous pieces of evidence and studies, the mechanisms, molecules, and components involved in the arbovirus replication cycles are yet to be defined. This chapter will discuss viral replication processes, immune evasion, and vaccine development for arboviral families that are relevant to public health.